GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (XCNQ:MMEN) » Definitions » Cyclically Adjusted Price-to-FCF

MedMen Enterprises (XCNQ:MMEN) Cyclically Adjusted Price-to-FCF : (As of Sep. 22, 2024)


View and export this data going back to 1987. Start your Free Trial

What is MedMen Enterprises Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedMen Enterprises Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for MedMen Enterprises's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Cyclically Adjusted Price-to-FCF Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MedMen Enterprises's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Cyclically Adjusted Price-to-FCF falls into.



MedMen Enterprises Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

MedMen Enterprises's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, MedMen Enterprises's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.013/127.3478*127.3478
=-0.013

Current CPI (Mar. 2023) = 127.3478.

MedMen Enterprises Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201304 -0.091 98.107 -0.118
201307 -0.152 98.557 -0.196
201310 -0.032 98.536 -0.041
201401 0.000 98.692 0.000
201404 -0.364 100.023 -0.463
201407 -0.059 100.520 -0.075
201410 0.038 100.176 0.048
201501 -0.061 98.604 -0.079
201504 -0.070 99.824 -0.089
201507 -0.055 100.691 -0.070
201510 -0.043 100.346 -0.055
201601 -0.051 99.957 -0.065
201604 -0.085 100.947 -0.107
201607 -0.044 101.524 -0.055
201610 -0.043 101.988 -0.054
201701 -0.055 102.456 -0.068
201704 -0.073 103.167 -0.090
201707 -0.063 103.278 -0.078
201710 0.000 104.070 0.000
201801 0.002 104.578 0.002
201804 -0.007 105.708 -0.008
201809 -1.997 106.507 -2.388
201812 -1.952 105.998 -2.345
201903 -0.967 107.251 -1.148
201906 -0.740 108.070 -0.872
201909 -0.427 108.329 -0.502
201912 -0.349 108.420 -0.410
202003 -0.088 108.902 -0.103
202006 -0.104 108.767 -0.122
202009 -0.058 109.815 -0.067
202012 -0.039 109.897 -0.045
202103 -0.034 111.754 -0.039
202106 -0.028 114.631 -0.031
202109 -0.032 115.734 -0.035
202112 -0.033 117.630 -0.036
202203 -0.014 121.301 -0.015
202206 -0.005 125.017 -0.005
202209 -0.010 125.227 -0.010
202212 -0.005 125.222 -0.005
202303 -0.013 127.348 -0.013

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MedMen Enterprises  (XCNQ:MMEN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


MedMen Enterprises Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises Business Description

Traded in Other Exchanges
N/A
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises Headlines

No Headlines